Citiva Medical Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Citiva Medical General Information

Description

Developer of cannabinoid medicine intended to deliver naturally sourced cannabinoid therapies that reduce suffering and treat disease safely. The company's products are used to treat conditions such as diabetes, epilepsy, chronic pain and various mental health disorders, enabling patients to receive tested, reliable and consistent treatment

Contact Information

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 14 Wall Street
  • New York, NY 10005
  • United States
+1 (212) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Citiva Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Citiva Medical‘s full profile, request access.

Request a free trial

Citiva Medical Executive Team (6)

Name Title Board Seat Contact Info
Kim Volman Co-Founder & Chief Executive Officer
Frank Turano Chief Financial Officer & Co-Founder
David Palmieri Chief Marketing Officer, Chief Operating Officer & Co-Founder
Josh Stanley Co-Founder
Jack D'Angelo Chief Medical Officer
You’re viewing 5 of 6 executive team members. Get the full list »